Page last updated: 2024-08-23

raloxifene hydrochloride and Demyelinating Diseases

raloxifene hydrochloride has been researched along with Demyelinating Diseases in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bebo, BF; Dehghani, B; Foster, S; Kurniawan, A; Lopez, FJ; Sherman, LS	1

Other Studies

1 other study(ies) available for raloxifene hydrochloride and Demyelinating Diseases

Article	Year
Treatment with selective estrogen receptor modulators regulates myelin specific T-cells and suppresses experimental autoimmune encephalomyelitis. Glia, 2009, Volume: 57, Issue:7 Topics: Animals; Cell Proliferation; Cells, Cultured; Demyelinating Diseases; Dendritic Cells; Encephalomyelitis, Autoimmune, Experimental; Estrogen Receptor alpha; Female; Genes, MHC Class II; Immunity, Cellular; Lipopolysaccharides; Mice; Mice, Knockout; Mice, Transgenic; Myelin Proteins; Myelin Sheath; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; T-Lymphocytes; Tamoxifen	2009

Article

Year

Treatment with selective estrogen receptor modulators regulates myelin specific T-cells and suppresses experimental autoimmune encephalomyelitis.

Glia, 2009, Volume: 57, Issue:7

Topics: Animals; Cell Proliferation; Cells, Cultured; Demyelinating Diseases; Dendritic Cells; Encephalomyelitis, Autoimmune, Experimental; Estrogen Receptor alpha; Female; Genes, MHC Class II; Immunity, Cellular; Lipopolysaccharides; Mice; Mice, Knockout; Mice, Transgenic; Myelin Proteins; Myelin Sheath; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; T-Lymphocytes; Tamoxifen

2009